1. Home
  2. HALO vs FBIN Comparison

HALO vs FBIN Comparison

Compare HALO & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • FBIN
  • Stock Information
  • Founded
  • HALO 1998
  • FBIN 1988
  • Country
  • HALO United States
  • FBIN United States
  • Employees
  • HALO N/A
  • FBIN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • FBIN Building Products
  • Sector
  • HALO Health Care
  • FBIN Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • FBIN Nasdaq
  • Market Cap
  • HALO 7.4B
  • FBIN 6.1B
  • IPO Year
  • HALO N/A
  • FBIN N/A
  • Fundamental
  • Price
  • HALO $52.81
  • FBIN $50.18
  • Analyst Decision
  • HALO Buy
  • FBIN Buy
  • Analyst Count
  • HALO 9
  • FBIN 12
  • Target Price
  • HALO $63.56
  • FBIN $79.42
  • AVG Volume (30 Days)
  • HALO 1.7M
  • FBIN 2.5M
  • Earning Date
  • HALO 08-05-2025
  • FBIN 07-24-2025
  • Dividend Yield
  • HALO N/A
  • FBIN 1.99%
  • EPS Growth
  • HALO 55.40
  • FBIN 4.88
  • EPS
  • HALO 3.76
  • FBIN 3.42
  • Revenue
  • HALO $1,084,306,000.00
  • FBIN $4,532,500,000.00
  • Revenue This Year
  • HALO $25.77
  • FBIN $0.43
  • Revenue Next Year
  • HALO $18.01
  • FBIN $3.89
  • P/E Ratio
  • HALO $14.04
  • FBIN $14.67
  • Revenue Growth
  • HALO 25.64
  • FBIN N/A
  • 52 Week Low
  • HALO $42.01
  • FBIN $47.21
  • 52 Week High
  • HALO $70.51
  • FBIN $90.54
  • Technical
  • Relative Strength Index (RSI)
  • HALO 41.21
  • FBIN 44.64
  • Support Level
  • HALO $53.54
  • FBIN $49.00
  • Resistance Level
  • HALO $55.60
  • FBIN $53.87
  • Average True Range (ATR)
  • HALO 1.24
  • FBIN 1.43
  • MACD
  • HALO 0.09
  • FBIN -0.04
  • Stochastic Oscillator
  • HALO 4.62
  • FBIN 32.66

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.3 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $723 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

Share on Social Networks: